OPINION: Ivermectin II: Cons and pros

Readers chastised us, saying we were promoting a COVID-19 drug that’s dangerous and unproven. Dr. Pierre Kory addresses those concerns.


  • By Matt Walsh
  • | 6:10 a.m. September 8, 2021
  • | 0 Free Articles Remaining!
  • Opinion
  • Share

Two weeks ago, we published on this page our urging to readers to read a long magazine article on the use of the drug ivermectin to treat COVID-19 — “The Drug That Cracked COVID.” You can read it at rescue.substack.com.

Written by New York Times bestselling author and journalist Michael Capuzzo for his and his wife Teresa’s Pennsylvania magazine, Mountain Home, the article chronicled the struggles of renowned academic medical researchers and physicians Drs. Pierre Kory and Paul Malik and others to convince public health agencies in the U.S. and around the world of the efficacy of ivermectin in the treatment of COVID-19 and that this FDA-approved, generic drug should be authorized for doctors to prescribe.

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news

Latest News

Sponsored Content